Ekso Bionics Holdings, Inc. (EKSO)

NASDAQ: EKSO · IEX Real-Time Price · USD

1.220

-0.080 (-6.15%)

At close: Jul 19, 2024, 4:00 PM

1.310

+0.090 (7.38%)

Pre-market: Jul 22, 2024, 8:36 AM EDT

Ekso Bionics Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2012
Net Income	-14.24	-15.2	-15.08	-9.76	-15.83	-12.13	Upgrade
Depreciation & Amortization	1.69	1.7	0.89	1.02	0.62	0.69	Upgrade
Share-Based Compensation	1.81	1.86	2.55	2.33	2.41	2.26	Upgrade
Other Operating Activities	-0.57	-0.41	-3.04	-4.74	4.04	-6.59	Upgrade
Operating Cash Flow	-11.31	-12.05	-14.69	-11.16	-8.76	-15.77	Upgrade
Capital Expenditures	-0.12	-0.16	-0.18	-0.06	0	-0.06	Upgrade
Acquisitions	0	0	-5	0	0	0	Upgrade
Investing Cash Flow	-0.12	-0.16	-5.18	-0.06	0	-0.06	Upgrade
Share Issuance / Repurchase	3.97	0.66	0	38.71	10.42	21.42	Upgrade
Debt Issued / Paid	-0.31	-0.31	0	0	0.29	-2.38	Upgrade
Financing Cash Flow	3.66	0.35	0	38.71	10.7	19.04	Upgrade
Exchange Rate Effect	-0.05	-0.02	-0.02	0.05	0.04	0.01	Upgrade
Net Cash Flow	-7.48	-11.89	-19.88	27.54	1.99	3.22	Upgrade
Free Cash Flow	-11.43	-12.21	-14.86	-11.22	-8.76	-15.83	Upgrade
Free Cash Flow Margin	-63.80%	-66.80%	-115.11%	-99.72%	-98.57%	-113.76%	Upgrade
Free Cash Flow Per Share	-0.66	-0.88	-1.15	-0.92	-1.22	-3.30	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).